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Summary
Aim of study The aim of this study is to compare demo-
graphic and clinical data as well as applied treatment 
methods in patients with rare benign and malignant tu-
mours of the oesophagus.
Methods Eight hundred and thirty patients with oe-
sophageal cancer were treated in the Department of Sur-
gical Oncology in 1960–2005. In 15 cases (1.8 %), rare be-
nign (n = 11) or malignant (n = 4) types of tumours were 
diagnosed. Patients with rare oesophageal tumours were 
included in the study, excluding those with squamous 
cell carcinoma or adenocarcinoma of the oesophagus. 
Demographic and clinical data were analysed from each 
patient qualified for the study. Oesophageal X-rays with 
contrast medium, gastroscopies and, as of 1991, com-
puted tomographies (CTs) were performed as preopera-
tive diagnostic procedures.
Results In the postoperative histopathological exami-
nations, all benign tumours proved to be oesophageal 
leiomyomas. Four different malignant tumours—a sar-
coma, a neuroendocrine carcinoma, a lymphoma and 
a squamous cell carcinoma in a patient with Crohn’s 
disease, were diagnosed in the other four patients. In 
a group of 15 patients with rare oesophageal tumours 
there were ten (66.7 %) males and five (33.3 %) females. 
In patients with benign and malignant tumours, the 
mean age for the benign group reached 44 years (range: 
26–75 years old) and 54.7 years (range: 47–59 years old) 
for the malignant group. In the preoperative period, 
symptoms such as swallowing disturbances, retrosternal 
pains and epigastric pains were observed. Dysphagia 
was the leading symptom in patients with benign and 
malignant oesophageal tumours.
Out of 15 patients, surgical procedure was carried 
out in 13 cases with rare oesophageal tumours. In the 
group of 11 patients, with benign tumours, ten (90.2 %) 
warranted surgical treatment. Three patients (75  %) 
with malignant oesophageal tumours underwent an 
extensive Akiyama procedure of oesophageal resection. 
Chemo- and radiotherapy alone were performed on one 
(25 %) patient with oesophageal lymphoma. Postopera-
tive complications were observed in only four (26.6 %) 
patients; pneumonia in the postoperative period was 
diagnosed in two patients who underwent surgery; in-
fections of the postoperative wounds were diagnosed in 
the other two patients.
Conclusions Benign oesophageal tumours are char-
acterized by similar clinical symptoms to malignant 
tumours of this organ. It is more complicated to obtain 
biopsy specimens for a histopathological examination in 
cases of benign tumours in comparison to malignant tu-
mours. Treatment methods should be adjusted individu-
ally for each patient with a rare oesophageal tumour. For 
rare benign oesophageal tumours, the results of treat-
ment are very good; however, for malignant tumours the 
prognosis depends on their histopathological type.
Keywords: Rare oesophageal tumours
Introduction
The most common oesophageal tumours are squamous 
cell carcinoma and adenocarcinoma. Other tumours 
are classified as rare oesophageal cancers and comprise 
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only 0.1–2  % [1–4]. Most commonly diagnosed benign 
oesophageal tumours include leiomyoma [5–7]; rare 
malignant oesophageal tumours include sarcomas, lym-
phomas, malignant melanomas and metastatic tumours 
of other malignant carcinomas [1–4, 8–12].
In 2008, the worldwide incidence of oesophageal 
cancer reached 482,000 patients and the mortality was 
406,000 cases [13]. In Poland in 2008, 895 new cases of 
oesophageal cancer were reported and 1,116 deaths due 
to the disease were registered. The raw incidence rate for 
oesophageal cancer was 4.9 per 100,000 inhabitants for 
men (age-standardized 3.4) and 1.23 per 100,000 inhabit-
ants for women (age-standardized 0.65) [14].
Besides other treatment options, surgery is always an 
alternative for curative intent in oesophageal carcinoma 
[14]. In patients with benign oesophageal tumours, 
enucleation of intramural lesions is the most commonly 
performed procedure. In exceptional cases, segmen-
tal oesophageal resections are carried out. Oesopha-
geal diverticula and benign oesophageal tumours are 
more commonly treated laparoscopically [15]. Other 
rare methods of treatment for benign oesophageal can-
cer include infrequently applied alcoholization [16]. For 
small leiomyomas in the form of polyps, endoscopic pol-
ypectomy is a possible treatment method. However, for 
malignant tumours extensive oesophageal resections are 
performed along with thoracic or cervical anastomoses. 
Chemotherapy and/or radiotherapy is the treatment of 
choice for patients with lymphoma.
Prognosis in oesophageal cancer depends on the 
histopathological diagnosis. After a radical resection 
of oesophageal benign tumour, the disease produces 
no impact on the patient’s life expectancy. In cases of 
rare malignant oesophageal tumours, life expectancy 
depends on the histopathological type of the tumour. 
Worldwide, 5-year life expectancy after radical treatment 
for oesophageal cancer is from 4 to 50 % [14]. In Poland, 
5-year life expectancy reaches 18.1 % [14, 16–18]. For lym-
phomas, the median life expectancy is 2 years, whereas 
for sarcomas the median life expectancy does not exceed 
the period of a few months [2–4].
The aim of this study is to compare the patients with 
rare benign and malignant oesophageal tumours treated 
in the Department of Surgical Oncology, in the area of the 
demographic and clinical data as well as in the applied 
methods of treatment.
Materials and methods
Eight hundred and thirty patients with oesophageal can-
cer (percentage squamous cell carcinoma vs adenocar-
cinoma in our center was 80 and 20 % respectively) were 
treated in the Department of Surgical Oncology between 
1960 and 2005. In 15 cases (1.8 %), rare benign or malig-
nant types of tumours were diagnosed. Patients with rare 
oesophageal tumours were included in the study, exclud-
ing those with squamous cell carcinoma or adenocar-
cinoma of the oesophagus. Demographic (age, sex) and 
clinical data were analysed from each patient qualified 
for the study, taking into account dysphagia, epigastric 
pain, digestive tract bleeding and retrosternal pain (after 
excluding cardiologic causes).
Radiological examination after barium meal (Barium 
sulfuricum, Polfa, Poland), gastroscopic examination 
with a biopsy specimen for a histopathological evalua-
tion and computed tomography (CT) were carried out 
as preoperative diagnostic procedures. Not all patients 
had a CT scan done, as the examination was not avail-
able in the department in the years 1960–1990. In radio-
logical examinations, exophytic and endophytic tumour 
types were considered pathological. The histopatho-
logical diagnosis was based on the endoscopic tumour 
biopsy specimen or on the postoperative microscopic 
evaluation.
The patients with rare oesophageal cancer were quali-
fied for surgical treatment of thoracotomy on the right 
side and enucleation of benign tumours. In any situation 
with damage to the oesophageal wall, partial resection 
of the oesophagus was performed along with a thoracic 
or cervical anastomosis. In the patients with polyp-like 
lesions diagnosed as leiomyoma, endoscopic polypec-
tomy was warranted. Chemotherapy and radiotherapy 
were applied for patients with lymphoma. The patients 
with malignant oesophageal cancer underwent an Aki-
yama procedure of oesophageal resection of its thoracic 
part [19].
Results
In the group of patients with rare oesophageal tumours 
(n = 15), there were 11 patients with benign tumours and 
four patients with malignant tumours.All benign tumours 
proved to be leiomyomas in the histopathological evalu-
ation. For the other four patients, different malignant 
tumours were diagnosed in each (sarcoma, neuroendo-
crine carcinoma, lymphoma and squamous cell carci-
noma in a patient with Crohn’s disease) (Table 1).
In the group of 15 patients with rare oesophageal 
cancer, there were ten (66.7 %) males and five (33.3 %) 
females. Men were more predisposed for either benign or 
malignant oesophageal cancer. The male-to-female ratio 
was respectively: 7/4 (M/F) and 3/1 (M/F). The mean age 
of patients with rare oesophageal cancer was 46.9 years 
(range: age 26–75). In the patients with benign and malig-
nant tumours, the mean age reached 44 years (range: age 
26–75) and 54.7 years (range: age 47–59), respectively.
In the preoperative period, symptoms such as swal-
lowing disturbances, retrosternal pains and epigastric 
pains were observed. Dysphagia was the leading symp-
tom in patients with benign and malignant oesophageal 
tumours, in nine (81.8 %) patients with benign tumours 
and in all the patients with malignant tumours. The 
mean duration of dysphagia for the studied group was 
11.4 months with a range of 0.75–24 months; for benign 
tumours the mean duration of dysphagia was 13.6 
months (range: 4–24 months) and for malignant tumours 
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the mean duration was 5.1 months (range: 0.75–8 
months). Retrosternal pain was another observed symp-
tom and was noted in six patients (40 %); in five patients 
(45.4 %) with benign tumour and in one patient (25 %) 
with malignant oesophageal tumour. For the whole 
group of patients, the mean duration of retrosternal pain 
was 8 months (range: 0.75–24 months). Epigastric pain 
was observed less frequently, as it was noted only in two 
patients (one patient with a benign tumour; one patient 
with a malignant tumour). Digestive tract bleeding 
was observed in only one patient (6.7 %) with a benign 
oesophageal tumour.
For the analysed group of patients, radiological 
examination in 11 (73.3 %) cases showed lesions in the 
oesophageal wall, whereas abnormalities in the mucosa 
were observed in only two (13.3 %) patients. In 10 out of 
11 patients with leiomyoma, the mucosa was intact; only 
one patient had changes within the mucosa in the form 
of a polyp. For the patients with malignant oesopha-
geal cancer, radiological examination with barium meal 
showed infiltrative changes in the oesophageal wall with 
irregularities of the mucosa. In the gastroscopic exami-
nation, all patients with benign oesophageal tumours 
had normal mucosa, with the exception of one patient 
with a polyp-like leiomyoma. However, the patients 
with malignant tumours had pathological changes of 
the mucous membrane in the form of ulceration in one 
(6.7 %) patient, polyp in one (6.7 %) patient and infil-
tration of the oesophageal wall in two (13.3 %) patients. 
CT was carried out in only four patients. In the group of 
patients with benign tumours, in one case an intramural 
tumour was found and in the another case we detected a 
Table 1. Demographic and clinical characteristics of patients with rare oesophageal tumours treated in the Department of 
Surgical Oncology in Gdansk, 1960–2005
Histopathological 
examination
Symptoms Radiological examination Gastroscopy Type of procedure Survival 
(months)
Benign tumours
Leiomyoma Epigastric and 
retrosternal pains
Polyp or intramural tumour Narrowing of the oesopha-
geal lumen, intact mucous 
membrane
Enucleation of the oe-
sophageal tumour through 
thoracotomy on the right
No influence 
on survival
Leiomyoma Dysphagia Intramural tumour
Leiomyoma Retrosternal pains Intramural tumour
Leiomyoma Dysphagia Intramural tumour
Leiomyoma Dysphagia and 
retrosternal pains
Impression of the oesophagus with 
smooth outlines; malignancy cannot be 
ruled out
Segmental resection of the 
oesophagus through thora-
cotomy on the left
Leiomyomatosis Dysphagia and 
bleeding
Narrowing of the oesophageal lumen Segmental resection of the 
oesophagus through thora-
cotomy on the right
Leiomyoma Dysphagia and 
retrosternal pains
4-cm-long narrowing of the oesopha-
geal lumen
Enucleation of the oe-
sophageal tumour through 
thoracotomy on the rightLeiomyoma Dysphagia Intramural tumour at the level of the 
aortic arch
Hyaline leiomyoma Retrosternal pains Intramural tumour or carcinoma
Leiomyoma Dysphagia Tumour localized at the back of the 
trachea, causing impression on the 
oesophagus
Narrowing in the upper 
third, intact mucous 
membrane
Leiomyoma Dysphagia Bulge (17 mm) of the oesophageal  
wall in its cervical segment





carcinoma of the oe-




Narrowing in the middle part (carci-
noma) in a patient with Crohn’s disease
Infiltrated mucous 
membrane with suspected 
carcinoma







Malignant circular infiltration in the 
cardiac segment
Malignant circular infiltration 





Carcinosarcoma Dysphagia Irregular thickening with lumen narrow-
ing in the lower part
Oesophageal narrowing, in-
filtrated mucous membrane 
in its lower third




carcinoma of high 
malignancya





aIn immunohistochemical examination: cytokeratin ( + ), chromogranin ( + ), synaptophysin ( + )
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small polyp in the oesophageal lumen. However, for the 
patients with malignant tumours the examination was 
available in two (50 %) cases, and for each of them CT 
scans showed neoplastic infiltration without progressing 
beyond the oesophageal wall.
Thirteen out of 15 patients with rare oesophageal 
tumours required surgical treatment. Ten (90.2  %) out 
of 11 patients with benign oesophageal tumours also 
required surgical treatment; in eight (72.7 %) cases an 
enucleation of the intramural tumour was performed, 
and in two (18.2 %) cases a segmental oesophageal resec-
tion with thoracotomy was carried out. In the group of 
patients with benign tumours, segmental resection of 
the oesophagus was performed due to infiltration of 
the oesophageal wall in one case and due to iatrogenic 
perforation of the oesophageal wall in the other. Only in 
one (9 %) patient with oesophageal leiomyoma polyp, an 
endoscopic polypectomy was carried out. In three (75 %) 
patients with malignant oesophageal cancer, excessive 
Akiyama resections of the oesophagus were performed. 
Gastrointestinal bleeding was found in only one (6.7 %) 
patient with a benign tumor of the esophagus.
Postoperative complications were observed only in 
four patients out of the group of 13 who required surgery. 
In two (13.3 %) cases, pneumonia was diagnosed in the 
postoperative period (one patient with benign tumour 
and one patient with malignant tumour). In two (13.3 %) 
patients with malignant tumour of the oesophagus, an 
infection of the postoperative wound was observed. 
Infectious complications subsided after an intravenous 
antibiotic therapy.
For those patients with benign tumour of the oesoph-
agus, the surgical procedure had no influence on life 
expectancy. However, for patients with rare malignant 
oesophageal tumours, the median life expectancy was 14 
months (range: 12–60 months).
Discussion
Rare tumours of the oesophagus are described, in gen-
eral, only in the form of case reports [1, 8–10, 15]. Col-
lecting a larger group of patients with rare oesophageal 
cancer is possible only in multi-centre studies or through 
data acquisition from one centre over many years. The 
patients reported in this study are a group of 15 rare 
cases of oesophageal cancer collected from a depart-
ment that has dealt with surgical treatment of oesopha-
geal tumours since the early 1960s. Of those patients 
treated for oesophageal cancer in this period of time, 
rare oesophageal tumours constituted only 1.8 % of diag-
noses. Other authors report a similar percentage of diag-
noses [5, 6]. The most numerous group of patients in the 
presented clinical material was the leiomyoma group. 
Hamouda et al. [5], reported similar observations. Unlike 
other authors, in our study we did not observe patients 
with malignant melanoma or carcinoid tumours [9, 10].
In the area of clinical symptoms, there are no differ-
ences between patients with rare oesophageal tumours 
and patients with squamous cell carcinoma or adeno-
carcinoma of the oesophagus. Dysphagia is the clinical 
symptom that is most commonly reported from patients 
with oesophageal cancer [5]. In the analysed group of 
patients, swallowing disturbances were observed in the 
majority of patients with benign tumours and in all the 
patients with malignant tumours.
Diagnostic procedures for patients with oesopha-
geal cancer do not differ from diagnostic procedures for 
patients with rare oesophageal tumours. In patients with 
rare oesophageal tumours, diagnosis is difficult due to 
discrete changes in radiological examinations with bar-
ium meal, which are observed in the majority of patients. 
Another difficulty in diagnostics of patients with benign 
oesophageal tumour is obtaining reliable material for a 
preoperative histopathological evaluation. According 
to Tay et al. [8], a transoesophageal ultrasound scan is 
an additional examination that improves the effective-
ness of preoperative biopsies. However, the authors of 
this paper had no possibility to use transoesophageal 
ultrasound scans to evaluate the advancement of the 
oesophageal cancer or to obtain material for a histopath-
ological examination, as the latter became available in 
the department only a few years ago. CT of the chest was 
a valuable complement to the diagnostics of oesophageal 
cancer, which led to the more normal diagnosis of intra-
mural oesophageal tumours, especially leiomyomas. Out 
of the cases of intramural oesophageal tumours, in one 
patient the CT showed no changes in the oesophageal 
wall. It is generally agreed in the literature that CT is a 
routine examination for oesophageal cancer [5, 6]. In the 
opinion of the authors of this paper, for patients with rare 
malignant tumours, preoperative diagnostics was easier 
in comparison with patients with benign intramural 
tumours. However, so far no such comparison has been 
presented.
A surgical approach is the principal method of treat-
ment for patients with rare oesophageal cancer, and a 
medical approach in the form of chemotherapy, radio-
therapy or endoscopic methods is exceptionally infre-
quent. The surgical approach that consists of enucleation 
of the tumour through thoracotomy is the method of 
choice for benign tumours; however, segmental oesoph-
ageal resection may be required in some patients. Indica-
tions for segmental oesophageal resection include large 
tumours tightly adhered to the mucous membrane or 
iatrogenic damaging of the oesophageal wall. An endo-
scopic enucleation of single leiomyomas has nowadays 
fallen out of favour, as only few oesophageal leiomyomas 
are pedunculated and endoscopic intramural removal of 
the oesophageal tumour creates risks for perforation of 
the oesophagus.
There are not many papers that evaluate the results 
of surgical treatment for the group of rare oesophageal 
tumours. Over the last 10 years in the literature, there 
has been no report of death after an enucleation of 
oesophageal leiomyoma; furthermore, complications 
such as pleural haematoma, postoperative infections 
or lack of tightness after an enucleation are very rare 
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[8, 11, 15]. However, no differences have been observed 
from the results of surgical treatment and oncological 
treatment for rare malignant oesophageal tumours ver-
sus squamous cell carcinoma or adenocarcinoma of the 
oesophagus.
Conclusion
The comparison of patients with rare benign and malig-
nant oesophageal tumours enabled the authors to show 
differences in the area of preoperative diagnostics and 
treatment of the patients. The patients with benign 
tumours have similar clinical symptoms to the patients 
with malignant tumours, although it is more difficult to 
obtain a reliable endoscopic biopsy specimen for a his-
topathological evaluation. If this procedure fails, then 
fine needle aspiration can be considered as a method to 
achieve a preoperative diagnosis. The treatment methods 
and long-term survival seem to be significantly different 
between the groups of patients with benign and malig-
nant tumours.
Conflict of interest 
The authors declare that there is no actual or potential 
conflict of interest in relation to this article.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution License which permits any use, 
distribution, and reproduction in any medium, provided the 
original author(s) and the source are credited.
References
 1. Suzuki H, Nakanishi Y, Taniguchi H, Shimoda T, Yamaguchi 
H, Igaki H, Tachimori Y, Kato H. Two cases of early-stage 
esophageal malignant melanoma with long-term survival. 
Pathol Int. 2008;58:432–5.
 2. Chung JJ, Kim MJ, Kie JH, Kim KW. Mucosa-associated 
lymphoid tissue lymphoma of the esophagus coexistent 
with bronchus-associated lymphoid tissue lymphoma of 
the lung. Yonsei Med J. 2005;46:562–6.
 3. Iwaya T, Maesawa C, Uesugi N, Kimura T, Ogasawara S, 
Ikeda K, Kimura Y, Mitomo S, Ishida K, Sato N, Saito K, 
Masuda T. True carcinosarcoma of the esophagus. Dis 
Esophagus. 2006;19:48–52.
 4. Gaur D, Kishore S, Saini S, Pathak V. Carcinosarcoma of the 
oesophagus. Singapore Med J. 2008;49:283–5.
 5. Hamouda AH, Chisholm E. Endoscopic alcohol injection 
as a tretment modality for oesophageal leiomyoma. Euro-
pean J Surg Oncol. 2008;34:122–4.
 6. Palanivelu C, Rangarajan M, Senthilkumar R, Velusamy 
M. Combined thoracoscopic and endoscopic manage-
ment of mid-esophageal benign lesions: use of the prone 
patient position – Thoracoscopic surgery for mid-esoph-
ageal benign tumors and diverticula. Surg Endosc-Ultras. 
2008;22:250–4.
 7. Didkowska J, Wojciechowska W, Zaton´ski W. Nowotwory 
złosliwe w Polsce w 2008 roku. 2010.
 8. Tay YC, Ng CT, Lomanto D, Ti TK. Leiomyoma of the 
oesophagus managed by thoracoscopic enucleation. Sin-
gapore Med J. 2006;47:901–3.
 9. Lu TJ, Huang TW, Lee SC. Primary malignant melanoma of 
the esophagus. Ann Saudi. 2008;28:458–60.
10. Gupta V, Kochhar R, Sinha SK, Das A. Primary malignant 
melanoma of the esophagus long-term survival after radi-
cal resection. J Thorac Oncol. 2009;4:1180–2.
11. Boran C, Sengul N, Balaban YH, Gurel S. Multinodular 
leiomyoma of the esophagus with internodular hydropic 
degeneration and bulbous serosal protrusions simi-
lar to cotyledonoid uterine leiomyoma. Dis Esophagus. 
2007;20:187–9.
12. Maggiani F, Debiec-Rychter M, Ectors N, Lerut A, Scolot R. 
Primary epithelioid sarcoma of the oesophagus. Virchows 
Arch. 2007;451:835–8.
13. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. 
Estimates of worldwide burden of cancer in 2008: GLOBO-
CAN 2008. Inter J Cancer. 2010;127:2893–917.
14. Zielinski J, Swierblewski M, Kruszewski WJ, Jaworski R, 
Haponiuk I, Irga N, Kopacz A, Jaskiewicz J. A single-center 
experience in surgical treatment of squamous cell oesoph-
ageal carcinoma in the years 1970–2007. Kardiochirurgia I 
Torakochirurgia Polska. 2011;8:71–6.
15. Mainprize KS, Dehn TCB. Laparoscopic management of 
pseudoachalasia, esophageal diverticulum, and benign 
esophageal stromal tumor. Dis Esophagus. 2001;14:73–5.
16. Earlam R, Cunha-Melo JR. Oesophageal aquamous 
cell carcinoma: a critical review of surgery. Br J Surg. 
1980;67:381–90.
17. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, 
Tijssen JG, Fockens P, Stalmeier PF, Ten Kate FJ, Van dekken 
H, Obertop H, Tilanus HW, van Lanschot JJ. Extended 
transtrhoracic resection compared with limited transhiatal 
resection for adenocarcinoma of the esophagus. N Engl J 
Med. 2002;347:1662–9.
18. Altorki N, Skinner D. Should en block esophagectomy be 
the standard of care for esophageal carcinoma? Ann Surg. 
2001;234:581–7.
19. Akiyama H, Tsurumaru M, Udagawa H, Kajlyama Y. Radical 
lymph node dissection for cancer of the thoracic esopha-
gus. Ann Surg. 1994;220:364–72.
